spot_img
25.5 C
London
HomeTOP STORIESAmgen Q3 beats on both lines; adjusts 2025 guidance ranges for revenue,...

Amgen Q3 beats on both lines; adjusts 2025 guidance ranges for revenue, EPS

Post Content 

spot_img

latest articles

explore more